FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886851488> ?p ?o ?g. }

• W2886851488 endingPage "1062" @default.
• W2886851488 startingPage "1054" @default.
• W2886851488 abstract "Patients with solid organ transplants (SOTs) have been excluded from programmed death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitor clinical trials due to concern for allograft rejection. The use of immune checkpoint inhibitor therapy remains controversial in transplant patients.A retrospective pilot evaluation was conducted to assess the safety and efficacy of PD-1 inhibitors in patients with liver transplantation (LT). The primary endpoint was the rate of allograft rejection. Secondary endpoints included overall response rate (ORR), progression free survival (PFS) and overall survival (OS). Translational objectives included evaluation of tumor PD-L1, tumor infiltrating lymphocytes (TILs) and allograft PD-L1 expression.Seven metastatic cancer patients with a history of LT who received PD-1 inhibitor therapy were included [hepatocellular carcinoma (HCC), n=5; melanoma, n=2]. Rejection was observed in 2 of 7 patients. When rejection occurs it appears to be an early event with a median time to rejection of 24 days in our cohort. One patient achieved a complete response (CR), 3 patients had progressive disease (PD) and 3 patients discontinued therapy prior to restaging assessments. Two of five patients with available tissue had PD-L1 expression in the allograft and both developed rejection. One of five evaluable patients had abundant TILs. Two of five evaluable patients had PD-L1 tumor staining. The single patient with both abundant TILs and PD-L1 staining obtained a response. The median OS and PFS were 1.1 (0.3-21.1) and 1.8 (0.7-21.1) months, respectively.In this pilot evaluation both preliminary efficacy (1 of 4) and allograft rejection (2 of 7) were exhibited in evaluable patients. Larger, prospective trials are needed to elucidate optimal patient selection." @default.
• W2886851488 created "2018-08-22" @default.
• W2886851488 creator A5015154136 @default.
• W2886851488 creator A5018257387 @default.
• W2886851488 creator A5020740072 @default.
• W2886851488 creator A5027586983 @default.
• W2886851488 creator A5030149155 @default.
• W2886851488 creator A5030233600 @default.
• W2886851488 creator A5059366804 @default.
• W2886851488 creator A5065114679 @default.
• W2886851488 creator A5078950000 @default.
• W2886851488 creator A5080536598 @default.
• W2886851488 creator A5088323172 @default.
• W2886851488 creator A5090687433 @default.
• W2886851488 date "2018-12-01" @default.
• W2886851488 modified "2023-10-15" @default.
• W2886851488 title "Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience" @default.
• W2886851488 cites W1517732299 @default.
• W2886851488 cites W1520373882 @default.
• W2886851488 cites W1819681752 @default.
• W2886851488 cites W1945298789 @default.
• W2886851488 cites W1987882302 @default.
• W2886851488 cites W2040087188 @default.
• W2886851488 cites W2125082756 @default.
• W2886851488 cites W2126453999 @default.
• W2886851488 cites W2132554273 @default.
• W2886851488 cites W2154685147 @default.
• W2886851488 cites W2210105857 @default.
• W2886851488 cites W2223436478 @default.
• W2886851488 cites W2269960584 @default.
• W2886851488 cites W2295766629 @default.
• W2886851488 cites W2300181798 @default.
• W2886851488 cites W2303235652 @default.
• W2886851488 cites W2394658251 @default.
• W2886851488 cites W2465734185 @default.
• W2886851488 cites W2512287004 @default.
• W2886851488 cites W2516629980 @default.
• W2886851488 cites W2518790973 @default.
• W2886851488 cites W2529221862 @default.
• W2886851488 cites W2535835299 @default.
• W2886851488 cites W2560460441 @default.
• W2886851488 cites W2572174216 @default.
• W2886851488 cites W2578082697 @default.
• W2886851488 cites W2583124762 @default.
• W2886851488 cites W2587536205 @default.
• W2886851488 cites W2604481266 @default.
• W2886851488 cites W2606367731 @default.
• W2886851488 cites W2611189127 @default.
• W2886851488 cites W2678992970 @default.
• W2886851488 cites W2737651375 @default.
• W2886851488 cites W2737895097 @default.
• W2886851488 cites W2739983085 @default.
• W2886851488 cites W2740910678 @default.
• W2886851488 cites W2763543378 @default.
• W2886851488 cites W2770613715 @default.
• W2886851488 cites W2774961787 @default.
• W2886851488 cites W2780967330 @default.
• W2886851488 doi "https://doi.org/10.21037/jgo.2018.07.05" @default.
• W2886851488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6286929" @default.
• W2886851488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30603124" @default.
• W2886851488 hasPublicationYear "2018" @default.
• W2886851488 type Work @default.
• W2886851488 sameAs 2886851488 @default.
• W2886851488 citedByCount "102" @default.
• W2886851488 countsByYear W28868514882018 @default.
• W2886851488 countsByYear W28868514882019 @default.
• W2886851488 countsByYear W28868514882020 @default.
• W2886851488 countsByYear W28868514882021 @default.
• W2886851488 countsByYear W28868514882022 @default.
• W2886851488 countsByYear W28868514882023 @default.
• W2886851488 crossrefType "journal-article" @default.
• W2886851488 hasAuthorship W2886851488A5015154136 @default.
• W2886851488 hasAuthorship W2886851488A5018257387 @default.
• W2886851488 hasAuthorship W2886851488A5020740072 @default.
• W2886851488 hasAuthorship W2886851488A5027586983 @default.
• W2886851488 hasAuthorship W2886851488A5030149155 @default.
• W2886851488 hasAuthorship W2886851488A5030233600 @default.
• W2886851488 hasAuthorship W2886851488A5059366804 @default.
• W2886851488 hasAuthorship W2886851488A5065114679 @default.
• W2886851488 hasAuthorship W2886851488A5078950000 @default.
• W2886851488 hasAuthorship W2886851488A5080536598 @default.
• W2886851488 hasAuthorship W2886851488A5088323172 @default.
• W2886851488 hasAuthorship W2886851488A5090687433 @default.
• W2886851488 hasBestOaLocation W28868514881 @default.
• W2886851488 hasConcept C121608353 @default.
• W2886851488 hasConcept C126322002 @default.
• W2886851488 hasConcept C141071460 @default.
• W2886851488 hasConcept C143998085 @default.
• W2886851488 hasConcept C167135981 @default.
• W2886851488 hasConcept C203092338 @default.
• W2886851488 hasConcept C2776694085 @default.
• W2886851488 hasConcept C2778019345 @default.
• W2886851488 hasConcept C2778822529 @default.
• W2886851488 hasConcept C2779609443 @default.
• W2886851488 hasConcept C2779984678 @default.
• W2886851488 hasConcept C2911091166 @default.
• W2886851488 hasConcept C535046627 @default.
• W2886851488 hasConcept C71924100 @default.

• next